102804-82-0

102804-82-0 structure
102804-82-0 structure

Name 2-[(4-methoxy-3-methyl-2-pyridinyl)-methylthio]-benzimidazole
Synonyms 2-(((4-methoxy-3-methylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole
Rabeprazole Impurity 12
Rabeprazole EP Impurity G
Rabrazole Impurity G (Methoxy Sulphide)
Rabrazole Impurity 5
2-{[(4-Methoxy-3-Methylpyridin-2-yl)Methyl]sulfanyl}-1H-1,3-benzodiazole
2-[[(4-Methoxy-3-methylpyridin-2-yl)methyl]sulfanyl]-1H-benzimidazole
Rabrazole Impurity G (Rabrazole Sulfide 4-Methoxy Analog/ 4-Desmethoxypropoxyl-4-Methoxy Rabrazole Sulfide)
4-Desmethoxypropoxyl-4-methoxy S-Deoxo Rabeprazole
Rabrazolesodium Impurity G
Rabrazole impurity 4/Rabrazole Impurity G/Rabrazole Sulfide 4-Methoxy Analog/2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfanyl]-1H-benzimidazole
Rabrazole Impurity G
Rabrazole Sulfide 4-Methoxy Analog
Rabrazole Imp G
Rabrazole Impurity 12
4-DesMethoxypropoxyl-4-Methoxy S-Deoxo Rabrazole
Rabrazole Impurity 12(Rabrazole Impurity G)
Rabrazolesodium Impurity R
2-(((4-methoxy-3-methylpyridin-2-yl)methyl)thio)
2-(((4-Methoxy-3-methylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole (Rabrazole Impurity)
1H-Benzimidazole, 2-[[(4-methoxy-3-methyl-2-pyridinyl)methyl]thio]
2-{[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfanyl}-1H-benzimidazole
Density 1.3±0.1 g/cm3
Boiling Point 504.7±60.0 °C at 760 mmHg
Molecular Formula C15H15N3OS
Molecular Weight 285.36400
Flash Point 259.0±32.9 °C
Exact Mass 285.09400
PSA 76.10000
LogP 3.49
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.678

~21%

102804-82-0 structure

102804-82-0

Literature: Arigen, Pharmaceuticals, Inc. Patent: EP2103608 A1, 2009 ; Location in patent: Page/Page column 17 ;

~90%

102804-82-0 structure

102804-82-0

Literature: Pingili, R. Reddy; Jambula, M. Reddy; Ganta, M. Reddy; Ghanta, M. Reddy; Sajja; Sundaram; Boluggdu, V. Bhaskar Pharmazie, 2005 , vol. 60, # 11 p. 814 - 818

~%

102804-82-0 structure

102804-82-0

Literature: Kuehler, Thomas C.; Swanson, Marianne; Shcherbuchin, Vladimir; Larsson, Hakan; Mellgard, Bjoern; Sjoestroem, Jan-Eric Journal of Medicinal Chemistry, 1998 , vol. 41, # 11 p. 1777 - 1788

~%

102804-82-0 structure

102804-82-0

Literature: Kuehler, Thomas C.; Swanson, Marianne; Shcherbuchin, Vladimir; Larsson, Hakan; Mellgard, Bjoern; Sjoestroem, Jan-Eric Journal of Medicinal Chemistry, 1998 , vol. 41, # 11 p. 1777 - 1788

~%

102804-82-0 structure

102804-82-0

Literature: Kuehler, Thomas C.; Swanson, Marianne; Shcherbuchin, Vladimir; Larsson, Hakan; Mellgard, Bjoern; Sjoestroem, Jan-Eric Journal of Medicinal Chemistry, 1998 , vol. 41, # 11 p. 1777 - 1788

~%

102804-82-0 structure

102804-82-0

Literature: Kuehler, Thomas C.; Swanson, Marianne; Shcherbuchin, Vladimir; Larsson, Hakan; Mellgard, Bjoern; Sjoestroem, Jan-Eric Journal of Medicinal Chemistry, 1998 , vol. 41, # 11 p. 1777 - 1788

~%

102804-82-0 structure

102804-82-0

Literature: Kuehler, Thomas C.; Swanson, Marianne; Shcherbuchin, Vladimir; Larsson, Hakan; Mellgard, Bjoern; Sjoestroem, Jan-Eric Journal of Medicinal Chemistry, 1998 , vol. 41, # 11 p. 1777 - 1788

~%

102804-82-0 structure

102804-82-0

Literature: Pingili, R. Reddy; Jambula, M. Reddy; Ganta, M. Reddy; Ghanta, M. Reddy; Sajja; Sundaram; Boluggdu, V. Bhaskar Pharmazie, 2005 , vol. 60, # 11 p. 814 - 818
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.